CSIMarket
 
Enzo Biochem Inc  (ENZ)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Enzo Biochem Inc Income Statement Quarterly

ENZ


Select the Financial Report:   Period:   Fiscal Year:

INCOME STATEMENT
(Quarterly GAAP In millions $)

(Jan 31 2024)
II. Quarter
(Oct 31 2023)
I. Quarter
(Jul 31 2023)
IV. Quarter
(Apr 30 2023)
III. Quarter
(Jan 31 2023)
II. Quarter
Royalty And License Fee Income - - - -
Total Revenue 8.55 7.81 -19,660.00 16.11 16.34
Cost of Revenue 4.33 4.35 26.39 14.47 15.08
Gross Profit 4.22 3.46 -19,686.39 1.64 1.26
Selling, Administration, Marketing 5.07 7.01 8.08 12.02 11.81
Depriciation & Amortization - - - - -
Research and Development Expense 0.58 0.85 -0.50 0.98 1.43
(Gain) Loss Related to Litigation Settlement - - - - -
OtherOperating Income Expense 0.00 - -19,708.93 0.00 -
Legal Fees 0.76 1.08 1.16 4.29 1.00
Total operating costs including COS 10.74 13.28 -19,673.80 31.75 29.32
Operating income/-loss -2.19 -5.48 13.80 -15.65 -12.98
Other Deductions / - Income
Interest expense 0.89 0.98 1.12 0.04 -
Interest income - - - - -
Net interest expense/-income 0.89 0.98 - 0.04 -
Investment Income, Interest - - - - 0.06
Foreign Currency Transaction Gain (Loss), before Tax 0.69 -1.01 0.93 -0.35 -1.47
Allowances, Health Care Trust Fund And Other - - - - -
Unexpected (Gain) Loss - - - - -
Other loss/ -income -2.91 0.23 13.60 -0.15 1.41
Fair Value Option Changes In Fair Value Gain Loss - - -0.82 - -
Other Noncash Income Expense - - -1.40 -0.46 -1.66
Total costs & expenses 9.42 13.48 -19,661.49 31.29 27.66
Income /-loss before income taxes -0.86 -5.68 1.49 -15.19 -11.32
Income taxes expenses/-benefit - - - - -
Income after income taxes -0.86 -5.68 -25.02 -15.19 -11.32
Net income/-loss of other equity - - 10.64 - -
Income/-loss from cont. Ops. -0.86 -5.68 12.12 -15.19 -11.32
Accounting change - - - - -
Discontinued operations -2.20 -0.94 -37.32 - -
Gain On Sale Of Discontinued Operations Net Of Tax - - 82.63 - -
Extraordinary items - - - - -
Net Income/-loss -3.06 -6.62 57.43 -15.19 -11.32
Noncontrolling interests - - - - -
Prefered dividends - - - - -
Other - - - - -
Income/-loss to shareholder -3.06 -6.62 57.43 -15.19 -11.32
EBIT 0.03 -4.70 1.49 -15.15 -11.32
EBITD 0.30 -4.43 1.49 -14.50 -10.67
EBITDA 0.30 -4.43 4.17 -14.50 -10.67


Per Share (GAAP Quarterly, in $) (Jan 31 2024)
II. Quarter
(Oct 31 2023)
I. Quarter
(Jul 31 2023)
IV. Quarter
(Apr 30 2023)
III. Quarter
(Jan 31 2023)
II. Quarter
Basic EPS (excl. extra items) -0.02 -0.11 -0.51 -0.31 -0.23
   Extraordinary items -0.04 -0.02 -1,153.56 0.00 0.00
Basic Net EPS -0.06 -0.13 1,153.05 -0.31 -0.23
Basic shares outstanding (Mill. of Units) 51.02 50.89 0.05 48.99 49.22
   EPS other shares - - - - -
Diluted Net EPS -0.06 -0.13 1,168.23 -0.31 -0.23
Diluted average shares (Mill. of Units) 51.02 50.89 49.48 48.99 49.22
Dividend per share - - - - -



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com